Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Morris

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Clinical Investigation|June 5, 2018
Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug releaseChristopher Szot, Saurabh Saha, Xiaoyan M Zhang, et al.
Nature Communications|November 18, 2022
Cancer cell survival depends on collagen uptake into tumor-associated stromaKuo-Sheng Hsu, James M Dunleavey, Christopher Szot, et al.
Nature Cardiovascular Research|October 2, 2025
ANTXR1 blockade enhances cardiac function in preclinical models of heart failureNicola Boccella, GuoJun Yu, Steven Seaman, et al.
Cell Reports|July 5, 2016
Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung CancerNadine S Jahchan, Jing Shan Lim, Becky Bola, et al.
Nature Medicine|June 2, 2014
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancerCassandra L Hodgkinson, Christopher J Morrow, Yaoyong Li, et al.
Cancer Cell|April 12, 2017
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor VasculatureSteven Seaman, Zhongyu Zhu, Saurabh Saha, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2025
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancerJessica Menis, Laurent Greiller, Pierre Demontrond, et al.
Cell Reports|November 29, 2023
Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capabilityYang Feng, Jaewon Lee, Liping Yang, et al.
Eclinicalmedicine|June 24, 2026
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UKRobert D Morgan, Catharine Porter, Cong Zhou, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Clinical Investigation|June 5, 2018
Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug releaseChristopher Szot, Saurabh Saha, Xiaoyan M Zhang, et al.
Nature Communications|November 18, 2022
Cancer cell survival depends on collagen uptake into tumor-associated stromaKuo-Sheng Hsu, James M Dunleavey, Christopher Szot, et al.
Nature Cardiovascular Research|October 2, 2025
ANTXR1 blockade enhances cardiac function in preclinical models of heart failureNicola Boccella, GuoJun Yu, Steven Seaman, et al.
Cell Reports|July 5, 2016
Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung CancerNadine S Jahchan, Jing Shan Lim, Becky Bola, et al.
Nature Medicine|June 2, 2014
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancerCassandra L Hodgkinson, Christopher J Morrow, Yaoyong Li, et al.
Cancer Cell|April 12, 2017
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor VasculatureSteven Seaman, Zhongyu Zhu, Saurabh Saha, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2025
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancerJessica Menis, Laurent Greiller, Pierre Demontrond, et al.
Cell Reports|November 29, 2023
Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capabilityYang Feng, Jaewon Lee, Liping Yang, et al.
Eclinicalmedicine|June 24, 2026
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UKRobert D Morgan, Catharine Porter, Cong Zhou, et al.
Pageof 4